摘要
随着对当前使用的抗生素产生的惊人耐药性,公众健康出现了严重的世界威胁。然而,在过去的50年,仅有两类新的抗生素(恶唑烷酮类和脂酞类)应用到临床。这表面采用常规策略发现新的抗生素的成功率是有限的,我们必须重新考虑我们发现抗生素的方案。近来正在追寻许多新策略,本文主要仅突出了抗生素发现的这些新策略的少许。这些包括基于结构的药物设计(SBDD)、基因组方法、抗毒力策略、针对不增殖细菌和噬菌体的应用。总之,在核磁共振、X晶体学和基因组进化方面的进展对抗菌药物的研究产生了重大影响。因此本文旨在利用这些技术新颖性、他们的优势、劣势和局限性来讨论搜索新的抗菌剂的最近策略。
关键词: 酰化的高丝氨酸内酯,抗生素,抗生素的发现,抗毒力策略,自诱导物,噬菌体,基因组方法,不增殖细菌,噬菌体疗法,群体感应,抵抗力,筛选策略,基于结构的药物设计
Current Medicinal Chemistry
Title:Renaissance in Antibiotic Discovery: Some Novel Approaches for Finding Drugs to Treat Bad Bugs
Volume: 22 Issue: 18
Author(s): Bharat Gadakh and Arthur Van Aerschot
Affiliation:
关键词: 酰化的高丝氨酸内酯,抗生素,抗生素的发现,抗毒力策略,自诱导物,噬菌体,基因组方法,不增殖细菌,噬菌体疗法,群体感应,抵抗力,筛选策略,基于结构的药物设计
摘要: With the alarming resistance to currently used antibiotics, there is a serious worldwide threat to public health. Therefore, there is an urgent need to search for new antibiotics or new cellular targets which are essential for survival of the pathogens. However, during the past 50 years, only two new classes of antibiotics (oxazolidinone and lipopeptides) have reached the clinic. This suggests that the success rate in discovering new/novel antibiotics using conventional approaches is limited and that we must reconsider our antibiotic discovery approaches. While many new strategies are being pursued lately, this review primarily focuses only on a few of these novel/new approaches for antibiotic discovery. These include structure-based drug design (SBDD), the genomic approach, anti-virulence strategy, targeting nonmultiplying bacteria and the use of bacteriophages. In general, recent advancements in nuclear magnetic resonance, Xcrystallography, and genomic evolution have significant impact on antibacterial drug research. This review therefore aims to discuss recent strategies in searching new antibacterial agents making use of these technical novelties, their advantages, disadvantages and limitations.
Export Options
About this article
Cite this article as:
Bharat Gadakh and Arthur Van Aerschot , Renaissance in Antibiotic Discovery: Some Novel Approaches for Finding Drugs to Treat Bad Bugs, Current Medicinal Chemistry 2015; 22 (18) . https://dx.doi.org/10.2174/0929867322666150319115828
DOI https://dx.doi.org/10.2174/0929867322666150319115828 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Omega-3 Fatty Acids: Role in the Prevention and Treatment of Psychiatric Disorders
Current Psychiatry Reviews Tanshinone IIA Protects Hippocampal Neuronal Cells from Reactive Oxygen Species Through Changes in Autophagy and Activation of Phosphatidylinositol 3-Kinase, Protein Kinas B, and Mechanistic Target of Rapamycin Pathways
Current Neurovascular Research The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety AZT: An Old Drug with New Perspectives
Current Clinical Pharmacology Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?
Current Drug Safety HPV and Therapeutic Vaccines: Where are We in 2010?
Current Cancer Therapy Reviews Melatonin Therapy of Pediatric Sleep Disorders: Recent Advances, Why it Works, Who are the Candidates and How to Treat
Current Pediatric Reviews Hypoxia and Fetal Heart Development
Current Molecular Medicine Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress
Current Medicinal Chemistry A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors
Central Nervous System Agents in Medicinal Chemistry High-Level Bacterial Expression and Purification of Apicomplexan Micronemal Proteins for Structural Studies
Protein & Peptide Letters Inhibition of Proliferation and Induction of Apoptosis by Thymoquinone via Modulation of TGF Family, p53, p21 and Bcl-2α in Leukemic Cells
Anti-Cancer Agents in Medicinal Chemistry Efalizumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Lactoferrin as a Natural Immune Modulator
Current Pharmaceutical Design Vasotrophic Regulation of Age-Dependent Hypoxic Cerebrovascular Remodeling
Current Vascular Pharmacology Oxidative stress and myocarditis
Current Pharmaceutical Design Potential Targets for Intervention in Radiation-Induced Heart Disease
Current Drug Targets Intestinal Fibrosis in Crohns Disease: Medical Treatment or Surgery?
Current Drug Targets Drugs for AIDS
Mini-Reviews in Medicinal Chemistry Opposing Functions for the Wilms Tumor Protein 1 (WT1) in Tumorigenesis
Current Pediatric Reviews